Interestingly, it has been recently proposed that CDK1 is responsible for apoptosis resistance in BRAFV600E colorectal cancer; indeed, the combination of a CDK1 inhibitor with a MEK/ERK inhibitor enhanced apoptosis [41]. This evidence concerns the gene MAP2K7 and colorectal cancer.